An interventional study of Turmeric and Placebo in Thumb Osteoarthritis, sponsored by Massachusetts General Hospital. Recruiting at 1 site in United States. Open to participants aged 40 Years and older. Per ClinicalTrials.gov, last updated 2025-11-24.
Sponsored by Massachusetts General Hospital · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 13 studies in Osteoarthritis by Massachusetts General Hospital — 3 open to participants now, 4 under way, 1 of them phase 3. Osteoarthritis · Massachusetts General Hospital.
Among the 13 studies in Osteoarthritis by Massachusetts General Hospital, this one is the 6th largest by planned enrollment of the 10 interventional ones that give a count, is the only one that started in 2017, is one of 8 with no phase, and was the 8th registered.
2,978 studies on the registry are indexed under Osteoarthritis; 438 are open to participants now.
Browse Osteoarthritis studies →3 of the 13 studies in Osteoarthritis by Massachusetts General Hospital are open now, in 1 country. Recruiting first, the newest first:
Massachusetts General Hospital · Sites in United States
Ages 18+
Massachusetts General Hospital · Sites in United States
Ages 18+
By country, each count listing its studies:
Of the 285 Osteoarthritis studies recruiting now, 158 (55%) set no upper age limit and 70 (25%) stop at 75 or younger; 22 take children under 18; 31 take healthy volunteers.
This study: 40 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
13 studies; the count open now beside each. This study's row is marked.
First in 2010; this study’s year is marked. 1 started in 2017.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 60 is below the median of 80 across 2,242 interventional studies indexed under Osteoarthritis.
Median enrollment 85 across the 10 interventional studies, 400 across the 3 observational. Of the 6 that completed or were terminated, 6 (100%) have results posted.
This tab as a report to print or save as PDF → With an account.
Massachusetts General Hospital is the lead sponsor of 2,591 studies on the registry; 445 are open to participants now.
Of its 224 completed or terminated interventional studies of FDA-regulated products, 168 (75%) have results posted.
1 of the studies in Osteoarthritis by Massachusetts General Hospital that are under way reach primary completion within a year, 1 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06003101Phase 3Massachusetts General HospitalEffect of PRP, PPP, & BMAC on Functional Outcomes Following Hip Arthroscopy for Acetabular Labral Pathologies | 2027-08-30 |
Add it to your calendar (.ics) → With an account.
Among the 13 studies in Osteoarthritis by Massachusetts General Hospital, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The aim of this study is to assess whether the use of a commercially available nutraceutical, turmeric, is an effective option to manage pain and stiffness in patients with basal joint arthritis. To conduct a pilot Randomized Controlled Trial evaluating the impact of turmeric on basal joint arthritis.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.
Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.
Corticosteroids (steroids)
Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.
Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Subjects in this group will receive turmeric (100 mg pastille) 3 times per day for 6 weeks.
Dietary Supplement: Turmeric
Subjects in this group will receive a placebo pill 3 times per day for 6 weeks.
Other: Placebo
Drug pages: Turmeric extractStudies of Turmeric extractTurmeric extract pageHow we knowJudged by ClinicalTrials.gg, not part of the registry record. · Curcuma longaStudies of Curcuma longaCurcuma longa pageHow we knowJudged by ClinicalTrials.gg, not part of the registry record.
Subjects will receive turmeric (100 mg pastille) 3 times per day for 6 weeks.
Subjects in the control group will receive a placebo 3 times per day for 6 weeks.
Change in baseline pain intensity
0-10 ordinal rating of pain intensity
Time frame: Enrollment, 6 weeks, and 3 months
Change in baseline disability
Disability measured by the QuickDASH
Time frame: Enrollment, 6 weeks, and 3 months
Started Aug 2017 (actual). Primary completion is estimated for Dec 2027, 124 months after the start.
Of 578 non-industry interventional studies with no phase under Osteoarthritis, half reached primary completion within 26 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 51. This study's planned 124 months is above that.
Counting every sponsor, half of 713 studies reached it within 28 months; a quarter within 11 and three quarters within 57.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drugs tested here: Turmeric extract · Curcuma longa
Massachusetts General Hospital →